Atlas Trials

Leukemia Acute Myeloid

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Leukemia Acute Myeloid

RecordFirmDate
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies (NCT05362773)MacroGenics2022-07-13
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome (NCT03744390)Groupe Francophone des Myelodysplasies2019-04-02
Safety of Expanded Haploidentical Natural Killer Cells for Leukemia (NCT04327037)Belarusian Research Center for Pediatric Oncology, Hematology and Immunology2019-01-02
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia (NCT02665065)Actinium Pharmaceuticals2016-06-01
Epigenetic Reprogramming in Relapse AML (NCT02412475)Michael Burke2015-02-21
Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation (NCT01700751)Washington University School of Medicine2013-02-25
Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052) (NCT00687323)Merck Sharp & Dohme LLC2007-07-30

Track Leukemia Acute Myeloid automatically

Every clearance here is in the API, with alerts when new ones post.